QualityStocksNewsBreaks Archives - Page 9 of 1366

ThursdayMar 27, 2025 11:10 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Launches Investor Roadshow Highlighting Global Expansion Strategy

Brera Holdings (NASDAQ: BREA), an Ireland-based international sports club operator, has kicked off an investor roadshow in South Florida, with Executive Chairman Daniel McClory and CEO Pierre Galoppi presenting the company’s multi-club ownership ("MCO") strategy and recent growth developments. The sessions, taking place in West Palm Beach and Boca Raton, will showcase Brera’s expansion in both men’s and women’s football and its ongoing pursuit of new acquisitions in emerging markets. The roadshow follows recent momentum in global partnerships and portfolio growth aimed at driving long-term shareholder value. To view the full press release, visit https://ibn.fm/z5rx2 About Brera Holdings PLC Brera…

ThursdayMar 27, 2025 10:00 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement to Acquire Italian Biotech Pincell

Scinai Immunotherapeutics (NASDAQ: SCNI), announced it has signed a binding option agreement to acquire Pincell srl, an Italian biotech developing PC111, a first-in-class antibody targeting severe skin blistering disorders. In tandem, Scinai's Polish subsidiary submitted a €12 million non-dilutive grant application under the EU’s FENG program to fund the next development phase of PC111. The agreement positions Scinai to advance treatments for high-mortality conditions like pemphigus and Stevens-Johnson Syndrome without immunosuppression, with Pincell's leadership expected to integrate into Scinai’s expanding European operations. To view the full press release, visit https://ibn.fm/pzUzw About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical company with…

ThursdayMar 27, 2025 9:25 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Targets AI and Robotics Expansion with Pending Acquisitions

Nightfood Holdings (OTCQB: NGTF) announced it is nearing the completion of two key acquisitions—Carryout Supplies (S W C Group) and Skytech Automated Solutions—as part of its strategy to lead innovation at the intersection of AI, robotics and hospitality. The acquisition of Carryout Supplies is expected to close imminently, followed closely by the acquisition of Skytech, which recently expanded its AI-powered Laundry Helper robot to a second location. These moves mark a significant milestone in Nightfood’s evolution from a specialty food company to a hospitality tech innovator, with further strategic expansion under active consideration. To view the full press release, visit…

WednesdayMar 26, 2025 11:10 am

QualityStocksNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Stock Surges Amid AI Expansion Talks

Meta Platforms (NASDAQ: META) experienced a notable stock increase, closing up 3.9% on Monday, March 24, 2025. This surge follows reports of Meta's discussions with India's Reliance Industries to host Meta's AI models in a forthcoming data center in Jamnagar, Gujarat, projected to be the world's largest. The potential collaboration underscores Meta's commitment to expanding its artificial intelligence footprint in the rapidly growing Indian market. Additionally, Meta reported a 22% revenue increase in 2024, reaching $164.5 billion, reflecting robust growth in its core social media business. As of 10:28 AM EDT on March 26, 2025, Meta's stock is trading…

WednesdayMar 26, 2025 11:00 am

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Reports Strong 2024 Revenue Growth Driven by Core Services

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) reported a 14% increase in revenue for 2024, reaching $350 billion. The growth was primarily driven by its core services, with Google Search generating $198.1 billion (56.6% of total revenue) and YouTube Ads contributing $36.1 billion (10.3%). Google Cloud also saw significant growth, bringing in $43.2 billion (12.4%). The U.S. market accounted for approximately half of Alphabet's annual sales. As of 10:33 AM EDT on March 26, 2025, Alphabet's stock is trading at $170.28, reflecting a decrease of $2.51 (1.45%) from the previous close. To view the full article, visit https://ibn.fm/441og About Alphabet Inc.…

WednesdayMar 26, 2025 10:45 am

QualityStocksNewsBreaks – Amazon.com Inc. (NASDAQ: AMZN) Stock Rebounds Amid Positive AI Outlook Post-Nvidia Conference

Amazon.com (NASDAQ: AMZN) experienced a stock uptick following analyst optimism regarding its artificial intelligence (AI) prospects after Nvidia's recent GTC conference. Monness Crespi Hardt analyst Brian White highlighted Amazon Web Services' (AWS) potential to benefit from the growing generative AI sector, reiterating a buy rating with a price target of $215. Despite a seven-week decline in Amazon's stock amid a broader market downturn, analysts remain positive about the company's long-term growth, particularly in AI. As of 10:09 AM EDT on March 26, 2025, Amazon's stock is trading at $202.94, reflecting a decrease of $2.77 (1.35%) from the previous close. To…

WednesdayMar 26, 2025 10:35 am

QualityStocksNewsBreaks – Tesla Inc. (NASDAQ: TSLA) Stock Rises for Fifth Consecutive Session Amid Analyst Optimism

Tesla (NASDAQ: TSLA) has achieved its fifth consecutive day of stock gains, closing at $288.14 on Tuesday, March 25, 2025. This 3.5% increase brings the stock up 28% over the past five days, reversing a two-month decline. The rally comes despite reports of falling sales in the European Union for the second consecutive month. Analysts attribute the surge to CEO Elon Musk's encouragement for employees to retain their shares and confidence in Tesla's self-driving and robotics technology. Key resistance levels to monitor include $300, $385, and $680, while support levels are identified at $217 and $155. As of 10:13…

TuesdayMar 25, 2025 2:08 pm

QualityStocksNewsBreaks – Adageis Is Bringing AI to the Forefront of Value-Based Care

Adageis, a leading healthcare technology company, is at the forefront of an industry shift as providers increasingly prioritize specific, high-impact artificial intelligence (“AI”) applications that enhance patient care and financial performance. The company was featured in a recent article that discussed its innovative AI-driven solutions through its ProActive Care Platform, which offers practical applications that directly impact revenue generation and patient care. Adageis’ AI solutions stand distinct in providing key competencies in several areas including risk identification and early intervention, revenue tracking and forecasting, clinical decision support, administrative task automation, and continuous patient monitoring. Adageis’ platform demonstrates how AI can…

TuesdayMar 25, 2025 9:30 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Jones Las Vegas Technology and Innovation Conference

Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company advancing treatments for neurodegenerative diseases such as ALS and MS, will participate in the Jones Las Vegas Technology and Innovation Conference on April 8–9, 2025. Held at The Venetian Resort, the event will feature one-on-one meetings, panels, and networking with institutional investors. Clene CEO Rob Etherington will represent the company as it continues to highlight progress across its therapeutic pipeline. The conference is hosted by JonesTrading with marketing support from B2i Digital, Inc. To view the full press release, visit https://ibn.fm/WoJcw About Clene Inc. Clene (along with its subsidiaries, “Clene”) and its wholly owned…

TuesdayMar 25, 2025 9:20 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Taps IBN to Lead Corporate Communications Strategy

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, has selected IBN to manage its corporate communications and investor outreach. Soligenix is advancing late-stage clinical programs through its oncology and inflammation-focused Specialized BioTherapeutics segment and its Public Health Solutions division, which develops vaccines for biothreats such as ricin, Ebola, and Marburg. With support from roughly $60 million in non-dilutive funding and a pipeline that includes multiple orphan and fast-track designations, the company is preparing for potential regulatory approvals. IBN will amplify Soligenix’s message through its expansive media and investor network. To view the full article, visit https://ibn.fm/7hzf1 About Soligenix…

Site Search

Company Search

Category: QualityStocksNewsBreaks